Mesa Laboratories, Inc. (NASDAQ:MLAB) Director John James Sullivan sold 4,000 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $138.00, for a total value of $552,000.00. Following the completion of the sale, the director now owns 72,248 shares of the company’s stock, valued at $9,970,224. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) traded down $1.07 during mid-day trading on Tuesday, hitting $136.64. The company’s stock had a trading volume of 13,400 shares, compared to its average volume of 18,652. Mesa Laboratories, Inc. has a twelve month low of $117.58 and a twelve month high of $169.80. The stock has a market cap of $516.93, a PE ratio of 58.15 and a beta of 0.52. The company has a quick ratio of 1.64, a current ratio of 2.37 and a debt-to-equity ratio of 0.58.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Investors of record on Wednesday, February 28th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend is Tuesday, February 27th. Mesa Laboratories’s dividend payout ratio (DPR) is currently -64.00%.
MLAB has been the subject of several research reports. TheStreet upgraded Mesa Laboratories from a “c+” rating to a “b” rating in a report on Monday, November 6th. Zacks Investment Research upgraded Mesa Laboratories from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 9th. Finally, BidaskClub upgraded Mesa Laboratories from a “sell” rating to a “hold” rating in a report on Wednesday, February 7th.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Capital Analysts LLC purchased a new stake in shares of Mesa Laboratories during the 3rd quarter worth $128,000. SG Americas Securities LLC purchased a new stake in shares of Mesa Laboratories during the 3rd quarter worth $131,000. MetLife Investment Advisors LLC purchased a new stake in shares of Mesa Laboratories during the 4th quarter worth $183,000. Voya Investment Management LLC purchased a new stake in shares of Mesa Laboratories during the 2nd quarter worth $221,000. Finally, Westfield Capital Management Co. LP purchased a new stake in shares of Mesa Laboratories during the 3rd quarter worth $239,000. Hedge funds and other institutional investors own 72.77% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “John James Sullivan Sells 4,000 Shares of Mesa Laboratories, Inc. (MLAB) Stock” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://ledgergazette.com/2018/02/20/john-james-sullivan-sells-4000-shares-of-mesa-laboratories-inc-mlab-stock.html.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.